Methylprednisolone Use for DAH in HSCT Recipients and Implementation of an Evidence-Based Guideline

Download item | Update item information
Identifier 062_Ratte_EBPF2017
Title Methylprednisolone Use for DAH in HSCT Recipients and Implementation of an Evidence-Based Guideline
Creator Morgan Ratté, PharmD; Stephanie Sanders, PharmD, BCOP; Kathryn Elofson, PharmD; Estelle Harris, MD
Description Pulmonary complications occur in 25-50% of HSCT recipients and are a significant cause of morbidity and mortality.
Subject Methylprednisolone; Diffuse Alveolar Hemorrhage
Publisher Spencer S. Eccles Health Sciences Library, University of Utah
Date 2017
Date Digital 2017
Language eng
ARK ark:/87278/s6dc2d9s
Relation is Part of 2017 Evidence Based Practice Posters
Format application/pdf
Setname ehsl_ebp
Date Created 2019-02-05
Date Modified 2019-07-09
ID 1399431
Reference URL https://collections.lib.utah.edu/ark:/87278/s6dc2d9s
Back to Search Results